BOPCF
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q4 | 0.05 | $63M | $57M |
| 2025 Q2 | 0.06 | $77M | $34M |
| 2024 Q4 | 0.04 | $45M | $64M |
| 2024 Q2 | 0.06 | $79M | $48M |
| 2023 Q4 | 0.03 | $57M | $93M |
| 2023 Q2 | 0.05 | $79M | $30M |
| 2022 Q4 | 0.08 | $142M | $162M |
| 2022 Q2 | 0.05 | $76M | $23M |